Matthew Onorato

4.2k total citations
15 papers, 891 citations indexed

About

Matthew Onorato is a scholar working on Infectious Diseases, Surgery and Clinical Psychology. According to data from OpenAlex, Matthew Onorato has authored 15 papers receiving a total of 891 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 4 papers in Surgery and 4 papers in Clinical Psychology. Recurrent topics in Matthew Onorato's work include Antimicrobial Resistance in Staphylococcus (4 papers), Child and Adolescent Psychosocial and Emotional Development (4 papers) and Viral Infections and Outbreaks Research (3 papers). Matthew Onorato is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (4 papers), Child and Adolescent Psychosocial and Emotional Development (4 papers) and Viral Infections and Outbreaks Research (3 papers). Matthew Onorato collaborates with scholars based in United States, Canada and Jamaica. Matthew Onorato's co-authors include Nicholas A. Kartsonis, Robert F. Betts, Mark J. DiNubile, Jonathan Hartzel, Steven S. Smugar, Benedetto Vitiello, Graham J. Emslie, Neal D. Ryan, David A. Brent and Karen Dineen Wagner and has published in prestigious journals such as JAMA, American Journal of Psychiatry and Neurology.

In The Last Decade

Matthew Onorato

14 papers receiving 862 citations

Peers

Countries citing papers authored by Matthew Onorato

Since Specialization

Citations

This map shows the geographic impact of Matthew Onorato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Onorato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Onorato more than expected).

Fields of papers citing papers by Matthew Onorato

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Onorato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Onorato. The network helps show where Matthew Onorato may publish in the future.

Co-authorship network of co-authors of Matthew Onorato

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Onorato. A scholar is included among the top collaborators of Matthew Onorato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Onorato. Matthew Onorato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Single and Multiple Doses of Seladelpar Decrease Diurnal Markers of Bile Acid Synthesis in Mice 2025 ·PPAR Research ·Edward E. Cable, Jeffrey W. Stebbins, (unknown), Yun‐Jung Choi, (unknown), Sole Gatto, Matthew Onorato, Charles A. McWherter	0
2	DUX4 siRNA Optimization for the Development of an Antibody-Oligonucleotide Conjugate (AOC) for the Treatment of FSHD (P17-13.009) 2022 ·Neurology ·Barbora Malecová, David Sala, (unknown), (unknown), Rachel Johns, Joanne Young, (unknown), Sole Gatto, Matthew Onorato, Adam Pavlı́c̀ek, Orsolya Király, (unknown), Arthur A. Levin, Philipp Hadwiger, (unknown), Mark Stahl	2
3	Development of Pandemic Vaccines: ERVEBO Case Study 2021 ·Vaccines ·Jayanthi Wolf, (unknown), Sheri Dubey, Sean P. Troth, Matthew Onorato, Beth-Ann Coller, Mary E. Hanson, Jakub K. Simon	40
4	Immunogenicity, Lot Consistency, and Extended Safety of rVSVΔG-ZEBOV-GP Vaccine: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study in Healthy Adults 2019 ·The Journal of Infectious Diseases ·Scott A. Halperin, Rituparna Das, Matthew Onorato, Kenneth Liu, Jason Martin, Rebecca J. Grant-Klein, Richard Nichols, Beth-Ann Coller, F.A. Helmond, Jakub K. Simon	34
5	Six-Month Safety Data of Recombinant Vesicular Stomatitis Virus–Zaire Ebola Virus Envelope Glycoprotein Vaccine in a Phase 3 Double-Blind, Placebo-Controlled Randomized Study in Healthy Adults 2017 ·The Journal of Infectious Diseases ·Scott A. Halperin, José Ramón Arribas, Richard Rupp, Charles P. Andrews, Laurence Chu, Rituparna Das, Jakub K. Simon, Matthew Onorato, Kenneth Liu, Jason Martin, F.A. Helmond, (unknown)	56
6	Staphylococcus aureus Infections After Elective Cardiothoracic Surgery: Observations From an International Randomized Placebo-Controlled Trial of an Investigational S aureus Vaccine 2014 ·Open Forum Infectious Diseases ·Keith B. Allen, Vance G. Fowler, James S. Gammie, Jonathan Hartzel, Matthew Onorato, Mark J. DiNubile, Ajoke Sobanjo-ter Meulen	20
7	Prevalence of Pain-Predominant Functional Gastrointestinal Disorders and Somatic Symptoms in Patients with Anxiety or Depressive Disorders 2013 ·The Journal of Pediatrics ·Desale Yacob, (unknown), Jeffrey A. Bridge, (unknown), Matthew Onorato, Terrill Bravender, John V. Campo	47
8	Effect of an Investigational Vaccine for Preventing Staphylococcus aureus Infections After Cardiothoracic Surgery 2013 ·JAMA ·Vance G. Fowler, Keith B. Allen, Edson Duarte Moreira, Moustafa Sherief Moustafa, Frank Isgro, Helen W. Boucher, G. Ralph Corey, Yehuda Carmeli, Robert F. Betts, Jonathan Hartzel, Ivan S. F. Chan, Tessie McNeely, Nicholas A. Kartsonis, Dalya Güriş, Matthew Onorato, Steven S. Smugar, Mark J. DiNubile, Ajoke Sobanjo-ter Meulen	280
9	Out of the Black Box: Treatment of Resistant Depression in Adolescents and the Antidepressant Controversy 2012 ·Journal of Child and Adolescent Psychopharmacology ·Karen Dineen Wagner, Joan Rosenbaum Asarnow, Benedetto Vitiello, Gregory Clarke, Martin B. Keller, Graham J. Emslie, Neal D. Ryan, Giovanna Porta, Satish Iyengar, Louise Ritz, (unknown), Matthew Onorato, David A. Brent	10
10	The immunogenicity and safety of different formulations of a novel Staphylococcus aureus vaccine (V710): Results of two Phase I studies 2011 ·Vaccine ·Clayton Harro, Robert F. Betts, Jonathan Hartzel, Matthew Onorato, Joy Lipka, Steven S. Smugar, Nicholas A. Kartsonis	46
11	Treatment of Resistant Depression in Adolescents (TORDIA): Week 24 Outcomes 2010 ·American Journal of Psychiatry ·Graham J. Emslie, Taryn L. Mayes, Giovanna Porta, Benedetto Vitiello, Gregory N. Clarke, Karen Dineen Wagner, Joan Rosenbaum Asarnow, Anthony Spirito, Boris Birmaher, Neal D. Ryan, Betsy D. Kennard, Lynn DeBar, James T. McCracken, Michael Strober, Matthew Onorato, Jamie Zelazny, (unknown), Satish Iyengar, David A. Brent	132
12	Safety and Immunogenicity of a Novel Staphylococcus aureus Vaccine: Results from the First Study of the Vaccine Dose Range in Humans 2010 ·Clinical and Vaccine Immunology ·Clayton Harro, Robert F. Betts, Walter A. Orenstein, (unknown), Howard Greenberg, Matthew Onorato, (unknown), Joy Lipka, Mark J. DiNubile, Nicholas A. Kartsonis	46
13	Pentavalent Rotavirus Vaccine in Developing Countries: Safety and Health Care Resource Utilization 2010 ·PEDIATRICS ·C D C Christie, (unknown), (unknown), Matthew Onorato, (unknown), (unknown), Robbin Itzler, Mark J. DiNubile, Penny M. Heaton	15
14	Substance Use and the Treatment of Resistant Depression in Adolescents 2009 ·Journal of the American Academy of Child & Adolescent Psychiatry ·Benjamin I. Goldstein, Wael Shamseddeen, Anthony Spirito, Graham J. Emslie, Gregory N. Clarke, Karen Dineen Wagner, Joan Rosenbaum Asarnow, Benedetto Vitiello, Neal D. Ryan, Boris Birmaher, Taryn L. Mayes, Matthew Onorato, Jamie Zelazny, David A. Brent	47
15	Association of FKBP5 Polymorphisms With Suicidal Events in the Treatment of Resistant Depression in Adolescents (TORDIA) Study 2009 ·American Journal of Psychiatry ·David A. Brent, Nadine Melhem, Robert E. Ferrell, Graham J. Emslie, Karen Dineen Wagner, Neal D. Ryan, Benedetto Vitiello, Boris Birmaher, Taryn L. Mayes, Jamie Zelazny, Matthew Onorato, Bernie Devlin, Gregory N. Clarke, Lynn DeBar, (unknown)	116

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact